Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/53150
Conference/Presentation Title: Correlation between PI-RADS score and prostate core biopsy histopathology.
Authors: Sin J.;Rorke S.
Monash Health Department(s): Pathology
Institution: (Sin) Faculty of Medicine, Nursing and Health Sciences, Monash University, VIC, Australia
(Sin, Rorke) Department of Anatomical Pathology, Monash Health, VIC, Australia
Presentation/Conference Date: 23-Jan-2025
Copyright year: 2025
Publisher: Elsevier B.V.
Publication information: Pathology. Conference: Pathology Update 2025. Melbourne Convention and Exhibition Centre, Melbourne Australia. 57(Supplement 1) (pp S66-S67), 2025. Date of Publication: 01 Feb 2025.
Journal: Pathology
Abstract: Background: Traditionally, prostate cancer (PCa) diagnosis relies on invasive biopsies. The introduction of the Prostate Imaging-Reporting and Data System (PI-RADS) has improved MRI interpretation, assisting with the detection and risk stratification of clinically-significant prostate cancer (csPCa).1,2 Aims: This project aims to investigate the role and correlation between PI-RADS and prostate core biopsy histopathology in staging csPCa at a large tertiary hospital. Method(s): We conducted a retrospective analysis of 106 patients at Monash Health who underwent MRI and subsequent prostate core biopsy between 1 January 2022 and 31 December 2022. The following characteristics were included: maximum PI-RADS score for each patient and ISUP grade groups of histopathology. Result(s): Of the 106 biopsies, 94% were PI-RADS 3,4 and 5 lesions, which had mean ISUP grades of 1.87, 1.73 and 7.75 respectively. Using Spearman's rank correlation coefficient, the rho coefficient was 0.3564 (p-value = 0.00018), demonstrating a strong correlation between ISUP grades and PI-RADS scores. Discussion(s): This study supports the role of PI-RADS as a triage tool for accurate detection and risk stratification of suspected csPCa. The statistically significant positive relationship between ISUP and PI-RADS scores reinforces the accuracy of MRI in diagnosing PCa and expediting treatment. References 1. Lomas DJ, Ahmed HU. All change in the prostate cancer diagnostic pathway. Nat Rev Clin Oncol 2020; 17: 372-81. 2. Gupta R, Mahajan M, Sharma P. Correlation between prostate imaging reporting and Data System Version 2, Prostate-Specific Antigen Levels, and local staging in biopsy-proven carcinoma prostate: a retrospective study. Int J Appl Basic Med Res 2021; 11: 32-5.Copyright © 2024
Conference Name: PATHOLOGY UPDATE 2025
Conference Start Date: 2025-02-21
Conference End Date: 2025-02-23
Conference Location: Melbourne Convention and Exhibition Centre, Melbourne, Australia
DOI: http://monash.idm.oclc.org/login?url=http://acs.hcn.com.au/?acc=36265&url=https://dx.doi.org/10.1016/j.pathol.2024.12.271
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/53150
Type: Conference Abstract
Subjects: histopathology
MRI scanner
nuclear magnetic resonance imaging
prostate cancer
Type of Clinical Study or Trial: Observational study (cohort, case-control, cross sectional, or survey)
Appears in Collections:Conferences

Show full item record

Page view(s)

10
checked on Feb 21, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.